Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

Insiders Menu
Roster
Transactions
Krystal Biotech, Inc. (KRYS)

DateNameTitleTypeSecuritySharesPriceValueOwnershipReported
06/30/2023ROSSI DINO ADirectorGrantStock Option (Right to Buy)6.8k$117.40$798.3k 06/30/2023
06/30/2023JANNEY DANIELDirectorGrantStock Option (Right to Buy)6.8k$117.40$798.3k 06/30/2023
06/30/2023Gangolli Julian SDirectorGrantStock Option (Right to Buy)6.8k$117.40$798.3k 06/30/2023
06/30/2023Mason ChristopherDirectorGrantStock Option (Right to Buy)6.8k$117.40$798.3k 06/30/2023
06/30/2023Sutherland Everett RandDirectorGrantStock Option (Right to Buy)6.8k$117.40$798.3k 06/30/2023
06/30/2023Mazzacco CatherineDirectorGrantStock Option (Right to Buy)2.2k$117.40$255.9k 06/30/2023
06/09/2023ORTH ANDREW C.Chief Commercial OfficerSaleCommon Stock5.3k$128.10$674k 06/09/2023
06/09/2023ORTH ANDREW C.Chief Commercial OfficerSaleCommon Stock6.9k$128.94$890.5k 06/09/2023
06/09/2023ORTH ANDREW C.Chief Commercial OfficerSaleCommon Stock333$129.70$43.2k 06/09/2023
06/09/2023ORTH ANDREW C.Chief Commercial OfficerExerciseStock Option (Right to Buy)12.5k$63.55$794.4k 06/09/2023
06/09/2023JANNEY DANIELDirectorSaleCommon Stock3.9k$129.29$508.8kDirectly beneficially owned by Alta Bioequities, L.P.06/08/2023
06/09/2023JANNEY DANIELDirectorSaleCommon Stock5k$128.84$644.2kDirectly beneficially owned by Alta Bioequities, L.P.06/08/2023
06/09/2023JANNEY DANIELDirectorSaleCommon Stock10k$128.53$1.3MDirectly beneficially owned by Alta Bioequities, L.P.06/08/2023
06/08/2023JANNEY DANIELDirectorSaleCommon Stock4.6k$127.96$589.1kDirectly beneficially owned by Alta Bioequities, L.P.06/08/2023
06/08/2023JANNEY DANIELDirectorSaleCommon Stock1.1k$129.02$138.4kDirectly beneficially owned by Alta Bioequities, L.P.06/08/2023
06/08/2023JANNEY DANIELDirectorSaleCommon Stock5.4k$128.73$693.6kDirectly beneficially owned by Alta Bioequities, L.P.06/08/2023
06/08/2023JANNEY DANIELDirectorSaleCommon Stock5k$127.96$639.8kDirectly beneficially owned by Alta Bioequities, L.P.06/08/2023
06/08/2023JANNEY DANIELDirectorSaleCommon Stock10k$127.96$1.3MDirectly beneficially owned by Alta Bioequities, L.P.06/08/2023
06/08/2023JANNEY DANIELDirectorSaleCommon Stock5k$127.86$639.3kDirectly beneficially owned by Alta Bioequities, L.P.06/08/2023
05/31/2023Krishnan Krish SPresident and CEOSaleCommon Stock18.9k$116.00$2.2M 05/31/2023
05/31/2023Krishnan Krish SPresident and CEOSaleCommon Stock5.7k$116.95$668.5k 05/31/2023
05/31/2023Krishnan Krish SPresident and CEOSaleCommon Stock400$117.61$47k 05/31/2023
05/31/2023Krishnan Krish SPresident and CEOSaleCommon Stock20.1k$115.98$2.3MBy Spouse05/31/2023
05/31/2023Krishnan Krish SPresident and CEOSaleCommon Stock4.6k$116.86$532.5kBy Spouse05/31/2023
05/31/2023Krishnan Krish SPresident and CEOSaleCommon Stock300$117.57$35.3kBy Spouse05/31/2023
05/31/2023Krishnan SumaPresident, R&DSaleCommon Stock20.1k$115.98$2.3M 05/31/2023
05/31/2023Krishnan SumaPresident, R&DSaleCommon Stock4.6k$116.86$532.5k 05/31/2023
05/31/2023Krishnan SumaPresident, R&DSaleCommon Stock300$117.57$35.3k 05/31/2023
05/31/2023Krishnan SumaPresident, R&DSaleCommon Stock18.9k$116.00$2.2MBy Spouse05/31/2023
05/31/2023Krishnan SumaPresident, R&DSaleCommon Stock5.7k$116.95$668.5kBy Spouse05/31/2023
05/31/2023Krishnan SumaPresident, R&DSaleCommon Stock400$117.61$47kBy Spouse05/31/2023
05/22/2023Romano KathrynChief Accounting OfficerExerciseStock Option (Right to Buy)12.5k$52.26$653.2k 05/19/2023
05/22/2023Romano KathrynChief Accounting OfficerExerciseStock Option (Right to Buy)12.5k$63.55$794.4k 05/19/2023
05/22/2023Romano KathrynChief Accounting OfficerSaleCommon Stock2.5k$105.80$266.7k 05/19/2023
05/22/2023Romano KathrynChief Accounting OfficerSaleCommon Stock2.6k$106.81$274.5k 05/19/2023
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy